Standard BioTools Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-39.1M | $-44.2M | $5.1M | $13.9M |
| FY2017 | $-24.1M | $-25.7M | $1.6M | $9.1M |
| FY2018 | $-25.2M | $-25.6M | $372.0K | $11.0M |
| FY2019 | $-35.2M | $-37.7M | $2.5M | $11.4M |
| FY2020 | $-15.4M | $-28.1M | $12.7M | $14.5M |
| FY2021 | $-44.1M | $-57.3M | $13.3M | $16.1M |
| FY2022 | $-89.4M | $-93.2M | $3.8M | $14.9M |
| FY2023 | $-43.3M | $-46.1M | $2.8M | $13.1M |
| FY2024 | $-143.5M | $-151.8M | $8.4M | $31.7M |
| FY2025 | $-74.3M | $-82.6M | $8.3M | $29.6M |